跳至主要内容
临床试验/JPRN-UMIN000011807
JPRN-UMIN000011807已完成未知

Effect of Olmesartan on left ventricular diastolic function in patients with chronic heart failure - Olmesartan on diastolic function in patients with chronic heart failure

Kobe University Graduate School of Medicine0 个研究点目标入组 64 人开始时间: 2013年9月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
64

研究概览

简要总结

The findings of our study indicate that left ventricular mass index for heart failure patients, who had received other ARBs, significantly decreased 6 months after the change-over to olmesartan despite similar blood pressures and further decreased after 12 months. This reduction tended to be more prominent in patients with left ventricular hypertrophy.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Hypotension (<90/50 mmHg) 2. Patients with acute coronary syndrome within 3-month, cerebral vascular disturbance, myocarditis, constrictive pericarditis and severe valvular disease. 3. Uncontrolled atrial fibrillation and flutter 4. Chronic kidney disease (Cr>3mg/dl) 5. Pateints with malignancy 6. Renal artery stenosis 7. Patient with pregnancy 8. Allergy of olmesartan 9. Patients who treated with ACEI

研究者

发起方
Kobe University Graduate School of Medicine

相似试验

Effect of Olmesartan on left ventricular diastolic... | 临床试验